Actuate Therapeutics, Inc.
Ownership
Ownership Structure
Who owns Actuate Therapeutics, Inc. (ACTU)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 35.8% of the shares are freely tradable; institutional investors hold 58.2%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BIOS CAPITAL MANAGEMENT, LP | 41.85 | 10,049,996 | +0.0 | 06/30/2026 |
| Voss Capital LLC | 7.18 | 1,725,000 | +0.0 | 06/30/2026 |
| BlackRock Inc | 1.78 | 427,153 | -1.1 | 03/31/2026 |
| Vanguard Capital Management, LLC | 1.67 | 400,529 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 0.95 | 228,331 | +9.9 | 03/31/2026 |
| Texas Capital Bank Wealth Management Services Inc | 0.43 | 102,612 | +8.5 | 06/30/2026 |
| Palogic Value Management LP | 0.42 | 100,000 | +0.0 | 03/31/2026 |
| Northern Trust Corp | 0.41 | 97,851 | -3.5 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 1.20 | 287,385 | +0.0 | 07/31/2026 |
| Vanguard Institutional Extnd Mkt Idx Tr | 0.44 | 106,048 | +0.0 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Schmitt Daniel M | President, CEO and Director | 301,716 | 296,044 $ | Aug 14, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | Schmitt Daniel M | President, CEO and Director | Other | 120,521 | 1.01 | 121,726 |
| Aug 14, 2026 | Schmitt Daniel M | President, CEO and Director | Other | 272,056 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.